These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24507841)

  • 1. Biomarkers in COPD.
    Agusti A; Sin DD
    Clin Chest Med; 2014 Mar; 35(1):131-41. PubMed ID: 24507841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease.
    MacNee W
    Ann Med; 2013 May; 45(3):291-300. PubMed ID: 23110517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease.
    Duvoix A; Dickens J; Haq I; Mannino D; Miller B; Tal-Singer R; Lomas DA
    Thorax; 2013 Jul; 68(7):670-6. PubMed ID: 22744884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unifying thoracic biomarkers: surfactant protein-D and beyond.
    Jaw JE; Sin DD
    Expert Rev Respir Med; 2012 Apr; 6(2):147-54. PubMed ID: 22455487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study.
    Sin DD; Leung R; Gan WQ; Man SP
    BMC Pulm Med; 2007 Oct; 7():13. PubMed ID: 17922919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple biomarkers predict disease severity, progression and mortality in COPD.
    Zemans RL; Jacobson S; Keene J; Kechris K; Miller BE; Tal-Singer R; Bowler RP
    Respir Res; 2017 Jun; 18(1):117. PubMed ID: 28610627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactant protein D as a biomarker for chronic obstructive pulmonary disease.
    Bowler RP
    COPD; 2012 Dec; 9(6):651-3. PubMed ID: 23244171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactant protein D in chornic obstructive pulmonary disease (COPD).
    Moreno D; Garcia A; Lema D; De Sanctis JB
    Recent Pat Endocr Metab Immune Drug Discov; 2014 Jan; 8(1):42-7. PubMed ID: 24506680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Club Cell-16 and RelB as Novel Determinants of Arterial Stiffness in Exacerbating COPD Patients.
    Labonté LE; Bourbeau J; Daskalopoulou SS; Zhang M; Coulombe P; Garland K; Baglole CJ
    PLoS One; 2016; 11(2):e0149974. PubMed ID: 26914709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving Concepts in Chronic Obstructive Pulmonary Disease Blood-Based Biomarkers.
    Cazzola M; Puxeddu E; Ora J; Rogliani P
    Mol Diagn Ther; 2019 Oct; 23(5):603-614. PubMed ID: 31363933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD.
    Lomas DA; Silverman EK; Edwards LD; Locantore NW; Miller BE; Horstman DH; Tal-Singer R;
    Eur Respir J; 2009 Jul; 34(1):95-102. PubMed ID: 19164344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum Surfactant Protein D is a Potential Biomarker for Chronic Obstructive Pulmonary Disease: a Systematic Review and Meta-analysis.
    Wang H; Li F; Huang H; Wu F; Chen L; Zhang D; Zhang T; Wan Y
    Clin Lab; 2019 Dec; 65(12):. PubMed ID: 31850711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort.
    Lomas DA; Silverman EK; Edwards LD; Miller BE; Coxson HO; Tal-Singer R;
    Thorax; 2008 Dec; 63(12):1058-63. PubMed ID: 18757456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of systemic inflammatory biomarkers to predict mortality in chronic obstructive pulmonary disease.
    Kelly E; Owen CA; Pinto-Plata V; Celli BR
    Expert Rev Respir Med; 2013 Feb; 7(1):57-64. PubMed ID: 23362815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma cytokine profiles related to smoking-sensitivity and phenotypes of chronic obstructive pulmonary disease.
    Nakamura M; Nakamura H; Minematsu N; Chubachi S; Miyazaki M; Yoshida S; Tsuduki K; Shirahata T; Mashimo S; Takahashi S; Nakajima T; Tateno H; Fujishima S; Betsuyaku T
    Biomarkers; 2014 Aug; 19(5):368-77. PubMed ID: 24842387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease.
    Lock-Johansson S; Vestbo J; Sorensen GL
    Respir Res; 2014 Nov; 15():147. PubMed ID: 25425298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.
    Singh D; Roche N; Halpin D; Agusti A; Wedzicha JA; Martinez FJ
    Am J Respir Crit Care Med; 2016 Sep; 194(5):541-9. PubMed ID: 27585383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers of extracellular matrix turnover are associated with emphysema and eosinophilic-bronchitis in COPD.
    Bihlet AR; Karsdal MA; Sand JM; Leeming DJ; Roberts M; White W; Bowler R
    Respir Res; 2017 Jan; 18(1):22. PubMed ID: 28103932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.